Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06928298 · ClinicalTrials.gov registry record · NA

Cognitive Screening Made Easy for PCPs - Administrative Supplement

A NA study of Cognitive Impairment and Cognitive Decline, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
3
Study locations

NCT06928298: Recruiting NA study of Cognitive Impairment and Cognitive Decline, sponsored by University of Texas at Austin.

NCT06928298 is a NA study of Cognitive Impairment and Cognitive Decline that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 100 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06928298, a NA study of Cognitive Impairment and Cognitive Decline, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
3
Study locations

Study Summary

This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will be easier to screen for cognitive impairment, increasing the number of older adults who are screened and thus identified and treated.

Primary Outcome

Combination of symbol matching and voice tasks, which generates a cognitive performance score ranging from 0 to 1 (high scores mean higher likelihood of cognitive impairment)

Interventions

  • BEHAVIORAL RACS app

Study Locations (3)

Texas

  • Family Wellness Clinic - Austin
  • University of Texas Health Austin Primary Care Clinic - Austin
  • UT Health San Antonio's Geriatrics and Supportive Care Clinic - San Antonio

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-10
Est. Completion 2027-04-30
Phase NA
University of Texas at Austin

257 total trials

What NCT06928298 shows while recruiting

NCT06928298 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (85% lower).

The record links to 3 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which RACS app is the first listed.

NCT06928298 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06928298 about?

NCT06928298 is a clinical study titled "Cognitive Screening Made Easy for PCPs - Administrative Supplement". This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will b...

What is the current status of trial NCT06928298?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-10. Estimated completion is 2027-04-30.

What conditions does trial NCT06928298 study?

This clinical trial studies the following conditions: Cognitive Impairment, Cognitive Decline, Dementia, Mild.

What interventions are being tested in trial NCT06928298?

The interventions under investigation include: RACS app (BEHAVIORAL).

Who is sponsoring clinical trial NCT06928298?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06928298 being conducted?

This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06928298's enrollment target sits among peer trials

100 41st of 105 higher than 62 of 105 other Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06928298, the US trial registry maintained by the National Library of Medicine. NCT06928298 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.